Mario Lacouture

20PUBLICATIONS
83CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Environmental epidemiologyMajor global burdens of diseasePredictive and prognostic markersCellular immunology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (20)

|Jul 25, 2026
Skin Abnormalities at Checkpoint Inhibitor Therapy Initiation Are Associated With Skin Rash Development in Oncology Patients.

|May 05, 2026
Benralizumab for Eosinophil-Related Cutaneous Adverse Events of Anticancer Therapy: A Phase II Trial.

|Oct 26, 2024
Management of human epidermal growth factor receptor inhibitors-related acneiform rash: A position paper based on the first Europe/USA Delphi consensus process.

Z Apalla, A Freites-Martinez, K Grafanaki

|Oct 09, 2024
Predictors of immediate and delayed cutaneous hypersensitivity reactions to paclitaxel.

Megan H Trager, Alyce M Kuo, Stephen W Dusza

|Apr 23, 2024
Immunologic Profiling of Immune-Related Cutaneous Adverse Events with Checkpoint Inhibitors Reveals Polarized Actionable Pathways.

Mario E Lacouture, Elena Goleva, Neil Shah

|Nov 21, 2023
Validation and Responsiveness of the English version of the Chemotherapy-Induced Alopecia Distress Scale (CADS) in Breast Cancer Patients.

L Kraehenbuehl, D Kang, A S Bang

Pageof 4

Frequent Collaborators

4 joint publications

Lukas Kraehenbuehl

3 joint publications

Elena Goleva

3 joint publications

Andrea P Moy

3 joint publications

Donald Y M Leung